Q3 FY2026 · ended Sep 30, 2026 · Revenue $69.17M, -2.1% YoY · Filed Nov 5, 2026
SkinHealth Systems Inc. (SKIN) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $69.2 million and a net loss of $888,000. Free cash flow was $11.2 million. As of Sep 30, 2026 it held $112.4 million in cash and investments and $21.3 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SKIN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Long Beach, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1818093
- Former names
- Beauty Health Co (until Apr 20, 2026); Vesper Healthcare Acquisition Corp. (until Apr 30, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $69.2M | $72.1M | $64.9M | $82.4M | $70.7M |
| Operating income | $5.0M | $3.6M | -$1.8M | $162,000 | -$6.2M |
| Net income | -$888,000 | -$2.7M | -$6.6M | -$8.1M | -$11.0M |
| Diluted EPS | -$0.14 | -$0.02 | -$0.05 | -$0.02 | -$1.74 |
| Operating cash flow | $11.3M | $2.7M | -$5.6M | $15.2M | $9.6M |
| Free cash flow | $11.2M | $2.2M | -$5.8M | $15.1M | $9.6M |
| Total assets | $389.1M | $486.6M | $473.2M | $499.8M | $503.6M |
| Total liabilities | $333.3M | $431.0M | $418.0M | $438.7M | $438.0M |
| Stockholders' equity | $55.8M | $55.6M | $55.2M | $61.1M | $65.7M |
| Cash and investments | $112.4M | $206.1M | $204.4M | $232.7M | $219.4M |
| Total debt | $21.3M | $21.8M | $22.9M | $14.4M | $379.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 14, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Oct 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 28, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 10, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 14, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
All 438 SkinHealth Systems Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.